Excelsior Medical Co Ltd
Excelsior Medical Co., Ltd., together with its subsidiaries, sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, China, the Philippines, Malaysia, and Indonesia. It operates in four segments: Excelsior, Dynamic, Arich, and Other. The company offers hemodialysis/plasma exchange; blood bags; artificial stomas; and health appliances. It is also involved in… Read more
Market Cap & Net Worth: Excelsior Medical Co Ltd (4104)
Excelsior Medical Co Ltd (TW:4104) has a market capitalization of $431.55 Million (NT$14.28 Billion) as of March 19, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #14129 globally and #479 in its home market, demonstrating a -0.92% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Excelsior Medical Co Ltd's stock price NT$75.80 by its total outstanding shares 188367456 (188.37 Million).
Excelsior Medical Co Ltd Market Cap History: 2015 to 2026
Excelsior Medical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $194.71 Million to $431.55 Million (8.29% CAGR).
Excelsior Medical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Excelsior Medical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Excelsior Medical Co Ltd's market cap is 0.06 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.63x
Excelsior Medical Co Ltd's market cap is 0.63 times its annual earnings
9.19x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $194.71 Million | $6.20 Billion | $379.00 Million | 0.03x | 0.51x |
| 2016 | $186.70 Million | $6.21 Billion | $389.56 Million | 0.03x | 0.48x |
| 2017 | $194.95 Million | $6.10 Billion | $399.05 Million | 0.03x | 0.49x |
| 2018 | $210.70 Million | $6.35 Billion | $451.56 Million | 0.03x | 0.47x |
| 2019 | $260.32 Million | $6.46 Billion | $514.75 Million | 0.04x | 0.51x |
| 2020 | $286.00 Million | $6.68 Billion | $571.67 Million | 0.04x | 0.50x |
| 2021 | $311.29 Million | $6.57 Billion | $607.15 Million | 0.05x | 0.51x |
| 2022 | $384.86 Million | $7.19 Billion | $667.45 Million | 0.05x | 0.58x |
| 2023 | $503.28 Million | $8.23 Billion | $746.61 Million | 0.06x | 0.67x |
| 2024 | $489.62 Million | $8.54 Billion | $771.26 Million | 0.06x | 0.63x |
Competitor Companies of 4104 by Market Capitalization
Companies near Excelsior Medical Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Excelsior Medical Co Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #168 globally with a market cap of $112.58 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #366 globally with a market cap of $60.54 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #434 globally with a market cap of $49.75 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1461 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #168 | McKesson Corporation | NYSE:MCK | $112.58 Billion | $920.35 |
| #366 | Cencora Inc. | NYSE:COR | $60.54 Billion | $325.18 |
| #434 | Cardinal Health Inc | NYSE:CAH | $49.75 Billion | $211.87 |
| #1461 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Excelsior Medical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Excelsior Medical Co Ltd's market cap moved from $194.71 Million to $ 431.55 Million, with a yearly change of 8.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$431.55 Million | -7.11% |
| 2025 | NT$464.57 Million | -5.12% |
| 2024 | NT$489.62 Million | -2.71% |
| 2023 | NT$503.28 Million | +30.77% |
| 2022 | NT$384.86 Million | +23.63% |
| 2021 | NT$311.29 Million | +8.84% |
| 2020 | NT$286.00 Million | +9.87% |
| 2019 | NT$260.32 Million | +23.55% |
| 2018 | NT$210.70 Million | +8.08% |
| 2017 | NT$194.95 Million | +4.42% |
| 2016 | NT$186.70 Million | -4.11% |
| 2015 | NT$194.71 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Excelsior Medical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $431.55 Million USD |
| MoneyControl | $431.55 Million USD |
| MarketWatch | $431.55 Million USD |
| marketcap.company | $431.55 Million USD |
| Reuters | $431.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.